Procter & Gamble (PG Quick QuotePG - Free Report) reported $22.39 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 3%. EPS of $1.99 for the same period compares to $1.93 a year ago.

The reported revenue represents a surprise of +1.05% over the Zacks Consensus Estimate of $22.15 billion. With the consensus EPS estimate being $1.90, the EPS surprise was +4.74%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how P&G performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic Sales Growth (YoY change) - Beauty: 6% compared to the 2.4% average estimate based on four analysts.
• Organic Sales Growth (YoY change) - Total P&G: 2% versus the four-analyst average estimate of 1%.
• Organic Sales Growth (YoY change) - Health Care: 1% versus 1.6% estimated by four analysts on average.
• Organic Sales Growth (YoY change) - Grooming: 3% versus 1.9% estimated by four analysts on average.
• Net Sales- Beauty: $4.14 billion compared to the $4 billion average estimate based on six analysts. The reported number represents a change of +6.5% year over year.
• Net Sales- Grooming: $1.82 billion versus $1.75 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +5.5% change.
• Net Sales- Corporate: $242 million compared to the $163.91 million average estimate based on six analysts. The reported number represents a change of +48.5% year over year.
• Net Sales- Fabric & Home Care: $7.79 billion versus $7.85 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1.1% change.
• Net Sales- Baby, Feminine & Family Care: $5.17 billion versus the six-analyst average estimate of $5.19 billion. The reported number represents a year-over-year change of +1.4%.
• Net Sales- Health Care: $3.22 billion versus the six-analyst average estimate of $3.22 billion. The reported number represents a year-over-year change of +2.3%.
• Earnings before income taxes- Beauty: $1.13 billion compared to the $1.16 billion average estimate based on two analysts.
• Earnings before income taxes- Grooming: $585 million versus $546.12 million estimated by two analysts on average.

View all Key Company Metrics for P&G here>>>

Shares of P&G have remained unchanged over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.